GENSIGHT BIOLOGICS S.A. (SIGHT) — key financial figures for fiscal year 2024 (in EUR), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2024)

€1.5M

Net Income/Loss (FY2024)

-€14.0M

Total Assets (FY2024)

€10.8M

Total Equity (FY2024)

-€26.9M

Cash Flows from Operating Activities (FY2024)

-€12.9M

Source: GENSIGHT BIOLOGICS S.A. annual_report filing (FY2024). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.